Effectively Identifying Compound-Protein Interactions by Learning from Positive and Unlabeled Examples
暂无分享,去创建一个
Hui Liu | Yang Wang | Shuigeng Zhou | Jihong Guan | Yi-Ping Phoebe Chen | Zhanzhan Cheng | Y. Chen | J. Guan | Shuigeng Zhou | Hui Liu | Zhanzhan Cheng | Yang Wang
[1] Damian Szklarczyk,et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..
[2] Yoshihiro Yamanishi,et al. Supervised prediction of drug–target interactions using bipartite local models , 2009, Bioinform..
[3] María Martín,et al. Activities at the Universal Protein Resource (UniProt) , 2013, Nucleic Acids Res..
[4] Chih-Jen Lin,et al. LIBLINEAR: A Library for Large Linear Classification , 2008, J. Mach. Learn. Res..
[5] Salvatore Alaimo,et al. Drug–target interaction prediction through domain-tuned network-based inference , 2013, Bioinform..
[6] Robert B. Russell,et al. SuperTarget and Matador: resources for exploring drug-target relationships , 2007, Nucleic Acids Res..
[7] Hiroki Kobayashi,et al. Integrating Statistical Predictions and Experimental Verifications for Enhancing Protein-Chemical Interaction Predictions in Virtual Screening , 2009, PLoS Comput. Biol..
[8] E. Marchiori,et al. Predicting Drug-Target Interactions for New Drug Compounds Using a Weighted Nearest Neighbor Profile , 2013, PloS one.
[9] Chih-Jen Lin,et al. LIBSVM: A library for support vector machines , 2011, TIST.
[10] Yoshihiro Yamanishi,et al. Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.
[11] Chee Keong Kwoh,et al. Drug-target interaction prediction by learning from local information and neighbors , 2013, Bioinform..
[12] Ian H. Witten,et al. The WEKA data mining software: an update , 2009, SKDD.
[13] Chuang Liu,et al. Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference , 2012, PLoS Comput. Biol..
[14] Mehmet Gönen,et al. Predicting drug-target interactions from chemical and genomic kernels using Bayesian matrix factorization , 2012, Bioinform..
[15] S. Eddy,et al. Pfam: the protein families database , 2013, Nucleic Acids Res..
[16] Evan Bolton,et al. Database resources of the National Center for Biotechnology Information , 2017, Nucleic Acids Res..
[17] K. Chou,et al. Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features , 2010, PloS one.
[18] Xiaoli Li,et al. Learning to Classify Texts Using Positive and Unlabeled Data , 2003, IJCAI.
[19] Damian Szklarczyk,et al. STITCH 4: integration of protein–chemical interactions with user data , 2013, Nucleic Acids Res..
[20] Wanli Zuo,et al. Learning from Positive and Unlabeled Examples: A Survey , 2008, 2008 International Symposiums on Information Processing.
[21] Shuigeng Zhou,et al. Computationally predicting protein-RNA interactions using only positive and unlabeled examples , 2015, J. Bioinform. Comput. Biol..
[22] Elena Marchiori,et al. Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..
[23] Yoshihiro Yamanishi,et al. Relating drug–protein interaction network with drug side effects , 2012, Bioinform..
[24] Chang Liu,et al. Predicting Drug–Target Interactions Using Probabilistic Matrix Factorization , 2013, J. Chem. Inf. Model..
[25] Roded Sharan,et al. Combining Drug and Gene Similarity Measures for Drug-Target Elucidation , 2011, J. Comput. Biol..
[26] Jean-Philippe Vert,et al. Protein-ligand interaction prediction: an improved chemogenomics approach , 2008, Bioinform..
[27] David S. Wishart,et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..
[28] Philip S. Yu,et al. Building text classifiers using positive and unlabeled examples , 2003, Third IEEE International Conference on Data Mining.
[29] H. Yabuuchi,et al. Analysis of multiple compound–protein interactions reveals novel bioactive molecules , 2011, Molecular systems biology.
[30] Xiaoli Li,et al. Ensemble Positive Unlabeled Learning for Disease Gene Identification , 2014, PloS one.
[31] Rémi Gilleron,et al. Learning from positive and unlabeled examples , 2000, Theor. Comput. Sci..
[32] Kiyoko F. Aoki-Kinoshita,et al. From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..
[33] The UniProt Consortium,et al. Update on activities at the Universal Protein Resource (UniProt) in 2013 , 2012, Nucleic Acids Res..
[34] Hui Liu,et al. Improving compound–protein interaction prediction by building up highly credible negative samples , 2015, Bioinform..
[35] Hao Ding,et al. Collaborative matrix factorization with multiple similarities for predicting drug-target interactions , 2013, KDD.
[36] Philip S. Yu,et al. Partially Supervised Classification of Text Documents , 2002, ICML.
[37] Thorsten Joachims,et al. Making large scale SVM learning practical , 1998 .
[38] Chee Keong Kwoh,et al. Positive-unlabeled learning for disease gene identification , 2012, Bioinform..
[39] R. Tagliaferri,et al. Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.
[40] Ni Li,et al. Gene Ontology Annotations and Resources , 2012, Nucleic Acids Res..
[41] Jean-Philippe Vert,et al. ProDiGe: Prioritization Of Disease Genes with multitask machine learning from positive and unlabeled examples , 2011, BMC Bioinformatics.
[42] Damian Szklarczyk,et al. STITCH 2: an interaction network database for small molecules and proteins , 2009, Nucleic Acids Res..